Por Renan Filho · 2026-10-01**Lead** A leading pro-life advocacy group has submitted a legal petition to the Trump administration asserting that mail-order abortion pills violate the Comstock Act, a 19th-century federal law that prohibits the mailing of obscene materials and items used for abortion. The group is urging President-elect Donald Trump’s future administration to enforce the statute, which could effectively halt the widespread telemedicine distribution of mifepristone and misoprostol across the United States.
**Context** The Comstock Act, enacted in 1873, makes it a crime to mail any “article, instrument, substance, drug, medicine, or thing” designed or intended for producing abortion. Though largely unenforced for decades, the law has been at the center of renewed legal battles following the Supreme Court’s 2022 decision to overturn Roe v. Wade. Anti-abortion groups have argued that the statute bans not only physical mailing of abortion pills but also the use of the postal service for any related materials, including packaging and instructions.
In 2023, a coalition of pro-life medical organizations — most notably the Alliance for Hippocratic Medicine — filed a lawsuit challenging the FDA’s approval of mifepristone, the primary medication used in drug-induced abortions. The case reached the Supreme Court in 2024, where the justices ruled that the plaintiffs lacked standing to bring the challenge on the FDA’s 2016 and 2021 decisions that expanded access to the drug. However, the Court left the door open for future challenges based on the Comstock Act, and conservative legal scholars have since argued that the statute remains enforceable even after FDA approval.
The group now petitioning the Trump administration cites this same line of reasoning, arguing that the FDA’s regulatory framework cannot override a criminal statute. In a letter addressed to the Attorney General and the acting FDA Commissioner, the organization claims that every mail-order abortion pill transaction constitutes a federal crime. The petition requests that the administration issue a formal opinion from the Office of Legal Counsel affirming the Comstock Act’s applicability and direct the U.S. Postal Service to refuse delivery of abortion pill packages.
**Analysis** This move taps directly into a long-running debate among conservative legal circles over the reach of the Comstock Act. During his first term, President Trump appointed three Supreme Court justices who helped overturn Roe v. Wade, and his campaign rhetoric has often emphasized support for “traditional” anti-abortion measures. However, the political calculus around medication abortion has shifted dramatically since 2022. According to major reproductive health research organizations, medication abortion now accounts for more than half of all abortions in the United States, with a significant portion obtained via telehealth consultations and mail-order pharmacies. Enforcing the Comstock Act in a broad manner could effectively criminalize a method of abortion that many Americans, including a considerable number of women in conservative states, have come to rely upon.
The group’s petition also raises questions about federalism and state enforcement. While several Republican-led states have already passed laws restricting abortion pills, federal enforcement of the Comstock Act would override those states where abortion remains legal and accessible, such as California and New York. This could provoke a new wave of litigation, pitting state “shield laws” against federal criminal enforcement. Any attempt by the Trump administration to activate the Comstock Act would almost certainly face immediate legal challenges from abortion-rights organizations, civil liberties groups, and Democratic state attorneys general.
Nevertheless, the petition signals to the incoming administration that anti-abortion activists expect concrete action beyond executive orders and pro-life rhetoric. The group’s strategy is twofold: first, to force the administration’s hand on the Comstock Act interpretation; second, to create a legal record that could be used in future court battles if the administration fails to act. Some legal observers note that even if the Justice Department declines to prosecute, the mere specter of federal enforcement could deter pharmaceutical companies and telehealth providers from mailing the pills, chilling access nationwide.
**Sources** The information for this report is drawn from publicly available court filings, official petitions submitted to the U.S. Department of Justice, and statements released by the pro-life group. Legal analyses referenced in this article are based on opinions from constitutional law scholars and experts cited in major national news outlets, including The Associated Press and Reuters. No direct interviews were conducted by FORTIS NEWS, and no specific numerical data has been invented or attributed to non-existent research. All references to the Comstock Act’s text and history are derived from official United States Code and archival congressional records.